I’d happily sell Marks & Spencer to buy this FTSE 100 growth stock

This FTSE 100 (INDEXFTSE: UKX) growth stock offers far better value than serial disappointer Marks and Spencer Group plc (LON:MKS), argues G A Chester.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

High street fixture Marks & Spencer (LSE: MKS) has struggled for two decades. It’s been a serial disappointer for long-term investors. Here, I’ll explain why I’d happily sell the stock today, and buy FTSE 100 software giant Micro Focus International (LSE: MCRO) instead.

History repeats

Numerous management teams have tried to crack the conundrum of how to get M&S on a path to sustainable growth. Multi-year transformation plans have come and gone. The dividend was slashed by 37.5% in 2000 to help fund one attempt, and by 33.3% in 2009 to help fund another.

When M&S embarked on its latest transformation plan, I wrote that I wouldn’t be at all surprised to see the past repeat itself and the dividend rebased. This has now happened, with the company having announced a 40% cut, alongside a rights issue to raise up to £600m.

Expensive joint venture

The reason for the cash call is to invest in a joint venture with online grocer Ocado. Management reckons this is “a strategically compelling route to unlock growth for M&S Food.” 

I’m not convinced. To me, it smacks of M&S having to do something, and desperation in the price it’s paying (up to £750m, including a deferred consideration of up to £187.5m, payable after five years).

Furthermore, the dividend cut doesn’t appear to be necessary on the known information, which suggests to me the joint venture may need further investment, or the company needs to up capital expenditure in core M&S. Whatever the reason for the seemingly disingenuous dividend cut, I see a perennially struggling business with an expensive joint venture that may or may not work out.

At a current share price of 282p, M&S trades on 10.2 times trailing 12-month earnings (with a rights issue to come, which will be dilutive to future near-term earnings per share). Meanwhile, a 40% dividend cut implies a forward yield of 4%. Given its long history as a serial disappointer, I just don’t see this as a stock I need to own.

Challenging integration

Micro Focus International hasn’t been without its problems recently. These stemmed from its reverse takeover of the software assets of Hewlett Packard Enterprise in September 2017. Integration was more challenging than expected. However, management saw no underlying issues with the end market of the product portfolio.

Following an encouraging trading update in November last year, I was hopeful the company’s annual results in February would be a catalyst for improved investor sentiment. This proved to be the case, with management reporting a significantly lower decline in revenue than it had guided, and saying “we believe the most disruptive issues experienced since completion are now behind us.”

Good value

The share price has risen strongly since the results, and the company still has work to do, but I continue to see good value in the stock at a current 1,925p. This represents 11.5 times forecast earnings for its financial year ending in October, and 10.4 times forecast earnings for fiscal 2020.

Meanwhile, the current-year forecast dividend gives a yield of 4.3%. This rises to 4.75% for fiscal 2010, with a forecast 10% rise in the payout (in line with earnings). All in all, I’d happily sell M&S to buy this FTSE 100 growth stock, which also offers a superior dividend yield.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »